Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

Gut

Volumn 67, Issue 4, 2018, Pages 616-624

  Moussata, Driffa ^a   Allez, Matthieu ^b   Cazals Hatem, Dominique ^c   Treton, Xavier ^c   Laharie, David ^d   Reimund, Jean Marie ^e   Bertheau, Philippe ^b   Bourreille, Arnaud ^f   Lavergne Slove, Anne ^g   Brixi, Hedia ^h   Branche, Julien ⁱ   Gornet, Jean Marc ^b   Stefanescu, Carmen ^c   Moreau, Jacques ^j   Marteau, Philippe ^k   Pelletier, Anne Laure ^l   Carbonnel, Franck ^m   Seksik, Philippe ^k   Simon, Marion ⁿ   Fléjou, Jean François ^k   Colombel, Jean Fréderic ^o   Charlois, Anne Laure ^a   Roblin, Xavier ^p   Nancey, Stéphane ^a   Bouhnik, Yoram ^c   Berger, Françoise ^a   Flourié, Bernard ^a   more..

^a CENTRE HOSPITALIER LYON SUD   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c BEAUJON HOSPITAL   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e HÔPITAL DE HAUTEPIERRE   (France)

^f UNIVERSITÉ DE NANTES   (France)

^g HÔPITAL LARIBOISIÈRE   (France)

^h SERVICE DE DERMATOLOGIE   (France)

ⁱ LILLE UNIVERSITY HOSPITAL   (France)

^j CHU RANGUEIL   (France)

^k HÔPITAL SAINT ANTOINE   (France)

^l BICHAT HOSPITAL   (France)

^m BICÊTRE HOSPITAL   (France)

ⁿ INSTITUT MUTUALISTE MONTSOURIS   (France)

^o MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

more..

Author keywords

COLONOSCOPY; COLORECTAL NEOPLASIA; ENDOSCOPIC PROCEDURES; IBD

Indexed keywords

ADULT; ARTICLE; BIOPSY; CANCER LOCALIZATION; CHROMOENDOSCOPY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL OUTCOME; COHORT ANALYSIS; COLONOSCOPY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; DUODENUM BIOPSY; DYSPLASIA; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HEALTH IMPACT ASSESSMENT; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; INTESTINE PREPARATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; NEOPLASM; PATIENT CODING; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOM BIOPSY; RISK FACTOR; ULCERATIVE COLITIS; CLINICAL TRIAL; COLORECTAL TUMOR; COMPLICATION; CONTROLLED STUDY; FRANCE; GASTROENTEROLOGY; HEALTH SURVEY; IMAGE ENHANCEMENT; MIDDLE AGED; NARROW BAND IMAGING; PREDICTIVE VALUE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY;

MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; FRANCE; GASTROENTEROLOGY; HUMANS; IMAGE ENHANCEMENT; INFLAMMATORY BOWEL DISEASES; MALE; MESALAMINE; MIDDLE AGED; NARROW BAND IMAGING; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 85011097320     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-311892     Document Type: Article

References (34)

1. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010;138:738-45.
2. Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013;7:1-33.
3. Mowat C, Cole A, Windsor AI, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571-607.
4. Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med 2015;372:1441-52.
5. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256-60.
6. van den Broek FJ, Stokkers PC, Reitsma JB, et al. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences. Am J Gastroenterol 2014;109:715-22.
7. Soetikno R, Subramanian V, Kaltenbach T, et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology 2013;144:1349-52.
8. Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015;148:639-51.
9. Kiesslich R, Neurath MF. Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight. Gut 2004;53:163-5.
10. Marion JF. An expensive and empty ritual: the continued use of random biopsy technique for detecting dysplasia in patients with colitis-pro. Inflamm Bowel Dis 2007;13:1271-2.
11. Kiesslich R, Goetz M, Lammersdorf K, et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007;132:874-82.
12. Zisman TL, Bronner MP, Rulyak S, et al. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines. Inflamm Bowel Dis 2012;18:2240-6.
13. Matsumoto T, Nakamura S, Jo Y, et al. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol 2003;98:1827-33.
14. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880-8.
15. Hurlstone DP, Sanders DS, Atkinson R, et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm? Gut 2007;56:838-46.
16. The Paris classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 2003;58(6 Suppl):S3-S43.
17. Tharian B, George N, Navaneethan U. Endoscopy in the diagnosis and management of complications of inflammatory bowel disease. Inflamm Bowel Dis 2016;22:1184-97.
18. Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002;51:130-1.
19. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
20. Marion JF, Waye JD, Present DH, et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008;103:2342-9.
21. Günther U, Kusch D, Heller F, et al. Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. Int J Colorectal Dis 2011;26:667-72.
22. Mooiweer E, van der Meulen-de Jong AE, Ponsioen CY, et al. Chromoendoscopy for surveillance in inflammatory bowel disease does not increase neoplasia detection compared with conventional colonoscopy with random biopsies: results from a large retrospective study. Am J Gastroenterol 2015;110:1014-21.
23. Carballal S, Maisterra S, López-Serrano A, et al. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD. Gut 2016. doi: 10. 1136/gutjnl-2016-312332. [Epub ahead of print 9 Sep 2016].
24. Hurlstone DP, Sanders DS, Lobo AJ, et al. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterization of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005;37:1186-92.
25. Rubio CA. Neoplasias of the colorectal crypts. Anticancer Res 2005;25:4551-8.
26. Matkowskyj KA, Chen ZE, Rao MS, et al. Dysplastic lesions in inflammatory bowel disease. Arch Pathol Lab Med 2013;137:338-50.
27. Rubio CA, Slezak P. The unique pathology of nonpolypoid colorectal neoplasia in IBD. Gastrointestinal Clin N Am 2014;24:455-68.
28. Low D, Mino-Kenudson M, Mizoguchi E. Recent advancement in understanding colitis-associated tumorigenesis. Inflamm Bowel Dis 2014;20:2115-23.
29. Gounaris E, Martin J, Ishihara Y, et al. Fluorescence endoscopy of cathepsin activity discriminates dysplasia from colitis. Inflamm Bowel Dis 2013;19: 1339-45.
30. Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010;59:666-90.
31. Gaidos JKJ, Bickston SJ. How to optimize colon cancer surveillance in inflammatory bowel disease patients. Inflamm Bowel Dis 2016;22:1219-30.
32. Rutter MD, Saunders BP, Wilkinson KH, et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004;53:1813-16.
33. Jegadeesan R, Navaneethan U, Gutierrez NG, et al. Pattern of inflammation on surveillance colonoscopy does not predict development of colitis-associated neoplasia. Inflamm Bowel Dis 2016;22:2221-8.
34. Navaneethan U, Kochhar G, Venkatesh PGK, et al. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis. J Crohns Colitis 2013;7:974-81.